Irish entrepreneurs Brian and Eamonn Fallon backed the online art marketplace to finalise its funding round.
"We’re very excited to have found Artfinder, a global marketplace, providing unique affordable art online and a Certified B Corporation too. Those ethical credentials are really important to us and give Artfinder a clear point of difference in the market. The company has shown tremendous progress growing its community of independent artists and we look forward to working with the team on taking Artfinder’s growth to new heights."
The London startup secured Series A backing from previous investors and new participants to accelerate growth.
"We have seen how our service has not only managed to cope with increasing demand but the testimonials from customer’s shows that fast, reliable and safe deliveries of pharmacy products is here to stay. With this funding we will accelerate our growth and promote our service to the masses. We are excited to be at the forefront of the digitisation of pharmacy shopping."
Grafton Capital has secured a majority position in Third Financial following a £7m investment.
"Our vision for the company is to be the go-to provider of technology and custody services for investment firms. While the backbone of our operation is the servicing of traditional wealth managers and advisers, there is also a huge appetite from a raft of exciting fintech companies that require back-end operations, custody and infrastructure to help them bring their innovations to market. Our FCA-regulated service gives all of our customers a cost-effective and holistic solution which is continually updated with new features in response to client needs."
Parkwalk led the follow-on investment round to support the market launch of the company's mental health assessment tool.
"Diagnosing mental health issues correctly in primary care can be difficult, due to time constraints and the fact that mental health conditions can be masked by physical symptoms. Delays in diagnosing—or misdiagnosis—mean that it can take several years for an individual with depression to be correctly diagnosed. For bi-polar disorder the average delay is six to eight years. The consequence of this is that many people suffer unnecessarily from debilitating symptoms that could be successfully treated. It is clear that faster and earlier diagnosis followed by the most appropriate treatment will improve the quality of life of affected individuals, while at the same time relieving pressure on the healthcare system"
